Acadian Asset Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$306K Buy
2025
Q1
$190K Sell
2024
Q4
$890K Sell
2024
Q3
$1.04M Buy
2024
Q2
$190K Buy
2024
Q1
$79K Buy